AndreasNicholasSaltosMD

Physician

Overview of Dr. Saltos

Dr. Andreas Saltos is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Maryland School of Medicine and has been in practice 8 years. He is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 20 publications and over 400 citings.

Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Book by Phone+1(813) 686-5102
Is this information wrong?

Education & Training

University of MarylandResidency, Internal Medicine, 2012 - 2015
University of Maryland School of MedicineClass of 2012
University of South Florida MorsaniFellowship, Hematology and Medical Oncology

Certifications & Licensure

FL State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors Start of enrollment: 2016 Nov 23
Completed
Phase 1, Phase 2
Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer Start of enrollment: 2018 Nov 29
Active, not recruiting
Phase 2
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC Start of enrollment: 2019 Feb 01
Active, not recruiting
Phase 1
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2019 Jul 25
Active, not recruiting
Phase 2
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC Start of enrollment: 2020 Nov 23
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, p...
Egbert F Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz-Ares Rodríguez, Jose M Pacheco, Bob T Li, David Planchard, Christina Baik, ...> ;The Lancet. Oncology. 2024 Apr 1
Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299.
Xi, M., Dudek, A., Scilla, K., Mamdani, H., Creelan, B., Saltos, A., Tanvetyanon, T., Chiappori, A.> ;JTO Clinical and Research Reports. 2023 Dec 1
Osimertinibafatinib as first-line treatment for patients with metastatic non-small cell lung cancer with anexon 19 deletion or exon 21 L858R mutation.
Gilardone, S., Thapa, R., Laborde, J., Chen, D., Melzer, D., Pellini, B., Shafique, M., Saltos, A., Creelan, B., Tanvetyanon, T., Chiappori, A., Simon, G., Haura, E., ...> ;Journal of Thoracic Disease. 2023 Nov 30
Race-inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?
Sonam Puri, Andreas N Saltos, Jhanelle E Gray> ;Cancer. 2023 Dec 1
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
Andreas N Saltos, Ben C Creelan, Tawee Tanvetyanon, Alberto A Chiappori, Scott J Antonia, Michael R Shafique, Milijana Ugrenovic-Petrovic, Samer Sansil, Anthony Neuger...> ;Lung Cancer. 2023 Sep 1
Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy.
Dung-Tsa Chen, Andreas N Saltos, Trevor Rose, Zachary J Thompson, Ram Thapa, Alberto Chiappori, Jhanelle E Gray> ;Cancers. 2023 Apr 28
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, Dana Foresman, Mengyu Xie, Joseph O Johnson, Theresa A Boyle, Brian Ruffell, Bradford A Perez, Scott J Antonia, Neal Ready...> ;Cancer Immunology Research. 2023 Apr 3
2 citations
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Sm...
Casey L Liveringhouse, Kujtim Latifi, Amalin G Asous, Nghi B Lam, Stephen A Rosenberg, Thomas J Dilling, Gretchen V MacMillan, Alberto A Chiappori, Eric B Haura, Ben C...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 15
2 citations
Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.
Kea Turner, Naomi C Brownstein, Zachary Thompson, Issam El Naqa, Yi Luo, Heather S L Jim, Dana E Rollison, Rachel Howard, Desmond Zeng, Stephen A Rosenberg, Bradford P...> ;Radiotherapy and Oncology. 2022 Feb 1
138 citations
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.
Benjamin C. Creelan, Chao Wang, Jamie K. Teer, Eric M. Toloza, Jiqiang Yao, Sungjune Kim, Ana Marie Landin, John E. Mullinax, James Saller, Andreas Saltos, David Noyes...> ;Nature Medicine. 2021 Aug 12
3 citations
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
Dung-Tsa Chen, Wenyaw Chan, Zachary J. Thompson, Ram Thapa, Amer A. Beg, Andreas Saltos, Alberto Chiappori, Jhanelle E. Gray, Eric B. Haura, Trevor Rose, Ben C. Creelan> ;Plos One. 2021 Jul 1
27 citations
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Can...
Bradford A. Perez, Sungjune Kim, Min-Hsuan Wang, Ahmad M. Karimi, Chase Powell, Jiannong Li, Thomas J. Dilling, Alberto Chiappori, Kujtim Latifi, Trevor Rose, Austin L...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Feb 1
3 citations
Pathology Issues in Thoracic Oncology: Histologic Characterization and Tissue/Plasma Genotyping May Resolve Diagnostic Dilemmas.
Ibiayi Dagogo-Jack, Andreas Saltos, Alice T. Shaw, Jhanelle E. Gray> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2017 Jan 1
68 citations
Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC).
Andreas Saltos, Michael Shafique, Alberto Chiappori> ;Frontiers in Oncology. 2020 Jul 16
6 citations
Breaking the Impasse: Advances in Treatment of Small Cell Lung Cancer.
Andreas Saltos, Scott J. Antonia> ;Clinics in Chest Medicine. 2020 Apr 16
9 citations
Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Sonam Puri, Andreas Saltos, Bradford A. Perez, Xiuning Le, Jhanelle E. Gray> ;Current Oncology Reports. 2020 Mar 5
70 citations
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.
Jhanelle E. Gray, Andreas Saltos, Tawee Tanvetyanon, Eric B. Haura, Ben C. Creelan, Scott J. Antonia, Michael Shafique, Hong Zheng, Wenjie Dai, James Saller, Zhihua Ch...> ;Clinical Cancer Research. 2019 Jan 1
14 citations
Clinical associations of mucin 1 in human lung cancer and precancerous lesions.
Andreas Saltos, Farah Khalil, Michelle Smith, Jiannong Li, Michael J. Schell, Scott J. Antonia, Jhanelle E. Gray> ;Oncotarget. 2018 Nov 2
13 citations
Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer.
Sandrine Niyongere, Andreas Saltos, Jhanelle E. Gray> ;Journal of Thoracic Disease. 2018 Jan 30
27 citations
Ambulatory cell phone injuries in the United States: An emerging national concern
Daniel Smith, Kristin M. Schreiber, Andreas Saltos, Sarah B. Lichenstein, Richard Lichenstein> ;Journal of Safety Research. 2013 Dec 1
Spetzler-Martin grade III arteriovenous malformations. Author reply.
J. Marc Simard, Michael T. Koltz, Adam J. Polifka, Andreas Saltos, Robert G. Slawson, Young Kwok, E. Francois Aldrich> ;Journal of Neurosurgery. 2013 Sep 1
38 citations
Long-term outcome of Gamma Knife stereotactic radiosurgery for arteriovenous malformations graded by the Spetzler-Martin classification.
Michael T. Koltz, Adam J. Polifka, Andreas Saltos, Robert G. Slawson, Young Kwok, E. Francois Aldrich, J. Marc Simard> ;Journal of Neurosurgery. 2013 Jan 1
Join now to see all

Lectures

Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Updated results.
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Hospital Affiliations

H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida